Calcific lesions are the last frontier of endovascular therapies
Catheterization and Cardiovascular Interventions · 2023-05 · 101 (6) · 1168-1169
DOI: 10.1002/ccd.30659 ↗Kurz gefasst
Kommentar in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 23.04.2023. Verfasst von Bernardo Cortese. Beteiligte Einrichtung: Fondazione Ricerca e Innovazione Cardiovascolare, Milano, Italy. Hauptthemen laut MEDLINE: Calcinosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Key Points This study brings new important insights on the role of drug‐coated balloons for calcific lesions management in peripheral interventions, being this therapeutic option less performant in longer calcifications, as assessed by PACSS methodology. The role of intravascular imaging and atherectomy devices, and if these rules can be applied also to coronary arteries is still not understood. Calcified arteries are the last frontier of endovascular interventions, and ongoing adequately powered studies will hopefully shed light on the best treatment for this complex scenario.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Fondazione Ricerca e Innovazione Cardiovascolare, Milano, Italy.
- DCB Academy, Milano, Italy.
- Cardioparc, Lyon, France.
ORCID-Profile: Bernardo Cortese
Zitieren
APA
Cortese, B. (2023). Calcific lesions are the last frontier of endovascular therapies. Catheterization and Cardiovascular Interventions, 101(6), 1168-1169. https://doi.org/10.1002/ccd.30659
Vancouver
Cortese B. Calcific lesions are the last frontier of endovascular therapies. Catheterization and Cardiovascular Interventions. 2023;101(6):1168-1169. doi:10.1002/ccd.30659
BibTeX
@article{Cortese2023,
author = {Cortese, Bernardo},
title = {Calcific lesions are the last frontier of endovascular therapies},
journal = {Catheterization and Cardiovascular Interventions},
year = {2023},
volume = {101},
number = {6},
pages = {1168--1169},
doi = {10.1002/ccd.30659}
}
EUVIMED